Animal Health

Successful treatment for animals

Our Animal Health business made sound progress, due to our core business segments of swine and small animals. In 2008, we concluded another successful year with net sales of EUR 467 million and a growth of +19.5 % in local currencies (+14.4 % on euro basis).

Products

Boehringer Ingelheim Animal Health has a wide range of products covering

  • Biologicals
  • Pharmaceuticals
  • Natural Care.

see Global Activities


back to matrix

Product Matrix

  •  
  • Horse
  • Cattle
  • Swine
  • Domestic animals
Pharmaceuticals: Ubrolexin®
Active Ingredient

Cefalexin and Kanamycin.

Pharmaceutical form and application

Intramammary suspension.

Characteristics

Treatment of clinical mastitis in lactating dairy cows for bacteria susceptible to the combination of cefalexin and kanamycin such as Staphylococcus aureus, Streptococcus dysgalactiae, Streptococcus uberis and Escherichia coli.

Application

For intramammary use.
Treat the infected quarter(s) twice, leaving an interval of 24 hours between treatments. Use the contents of one syringe (containing 200 mg cefalexin as monohydrate and 100,000 I.U. kanamycin as monosulphate) per quarter per treatment. Each syringe is for single use only.

Before infusion, the udder should be milked out completely, the teat should be thoroughly cleaned and disinfected and care should be taken to avoid contamination of the injector nozzle.

back to matrix
back to top